An extracorporeal therapy and a medical technology which involves the passing of blood through an apparatus which separates one of the targeted constituents and returns the remainder of the blood to the circulation is referred to as apheresis. The components that are withdrawn and removed include platelets, plasma, and leukocytes. The component contributing to a disease state is removed from the blood with the help of therapeutic apheresis. An example of components leading to the disease state is plasmapheresis, plateletpheresis, leukopheresis and stem cell harvesting. The demand for apheresis equipment is expected to rise in future due to rising blood disorder prevalence including blood cancer, sickle cell anemia, hemophilia and increasing the need for blood products. One of the genetic disorders is familial hypercholesterolemia which is also known as FH and the characterization is done on the basis of high cholesterol such as the bad cholesterol LDL. Patients who are suffering from breakdown or rhabdomyolysis related to the coronary heart disease or the disorder and are not responding to regular medical treatment are eligible for LDL-Apheresis. Cholesterol is widespread and therefore apheresis equipment is in great demand in order to treat patients. The market of apheresis is growing due to the increasing knowledge with respect to donation of blood with the help of apheresis. Hospitals dominated the end-users segment on account of the presence of high procedural volumes. The major drivers for the growth of apheresis equipment market are the growing prevalence of chronic diseases such as autoimmune diseases or cancer, the rise in the quantity of platelet donors, healthcare infrastructure improvement of developing nations, biopharmaceutical companies growing demand for plasma and reimbursement policies.
Key product segments analyzed in the report are devices and disposables. Devices held the largest market revenue due to its high price. Apheresis machine equipment dominated the market majorly owing to their high prices. However, the disposable apheresis equipment segment is expected to grow at the fastest rate during the forecast period. Increasing usage rates of disposable medical devices in an attempt to curb the incidence rates of hospital-acquired infections or HAIs and other infections such as bloodstream infection (BSI).
The application equipment market of apheresis equipment is classified into renal diseases, hematology, neurology and others. A neurological disorder dominated the market share and is expected to have the fastest growth during the forecast period owing to increasing plasma exchange due to growing rates of multiple sclerosis majorly in the U.S.
By procedure, the apheresis equipment market can be classified into plasmapheresis, LDL-apheresis, plateletpheresis, leukapheresis, photopheresis, erythrocytapheresis and others. Plasmapheresis has the largest segment in the entire apheresis equipment market. Plasmapheresis therapeutic applicability is widespread and the major driver for the rise in demand of plasmapheresis is its application in donor apheresis area whereas Photopheresis is the fastest growing segment owing to increasing rates of scleroderma and graft versus host disease (GVHD).
Key technology segments of apheresis equipment market are membrane filtration and centrifugation. Centrifugation is the fastest growing segment owing to its wider scope than the membrane separation due to the fact that membrane separation is restricted to only plasma exchange whereas centrifugation is used for the apheresis of any of the blood components.
Geographically, the global apheresis equipment market is categorized into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. North America has the largest market share followed by Europe .The United States holds the majority of the market share for apheresis equipment due to the factors such as well-established and advanced healthcare infrastructure, government support, high patient awareness and others. The fastest growing market is Asia Pacific and the factors responsible are the increasing rate of sickness and disease, growing expenditure on healthcare and most importantly growing population. It is anticipated that there would be a surge in investment by the leading companies of apheresis equipment in developing nations such as India and China.
Key players of this market include Asahi Kasei Kuraray Medical Co Ltd., Terumo BCT Inc., Fenwal Inc. Haemonetics Corp., Therakos Inc., B. Braun Melsungen AG, Hemacare Corporation, Kawasumi Laboratories Inc. and others.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.